Analyst Viewpoint
High efficacy of respiratory devices in the treatment of COPD is a prominent driver of the global respiratory devices market size. Inhalers and nebulizers are two primary respiratory devices that are utilized in the care of patients suffering from COPD. While other treatment modalities are available for the disease, the usage of respiratory devices has shown particularly promising results in patient prognosis. Rapid rate of technological advancements is also fueling market expansion.
Key players operating in the global market are focusing on scaling up their production capacities. They are also investigating the use of novel materials and delivery methods to reduce the price of devices. Favorable government regulations to fast-track the production of these devices and broaden their range of application are expected to provide novel respiratory devices market opportunities to companies operating in the global landscape.
The quality of respiratory devices has improved significantly in recent years. These modern instruments are used for a wide range of respiratory disorders. The emphasis on respiratory equipment and quality of life has increased substantially, particularly after the COVID-19 Pandemic. However, there are still many unknowns for patients.
It might be challenging to determine which device is ideal for each individual's medical condition. Someone suffering from chronic lung illness may require different breathing apparatus than someone suffering from other respiratory ailments.
Respiratory aids are devices designed to help patients requiring assistance with breathing and treatment to prevent disuse atrophy of abdominal wall muscles. Individuals who require breathing assistance tools such as oxygen therapy tools are often prescribed respiratory masks. These devices are utilized for a wide range of patients in the hospital, from newborns with underdeveloped lungs to the elderly with persistent respiratory difficulties.
COPD, or chronic obstructive pulmonary disease, is the biggest cause of mortality in the world today. The condition is distinguished by chronic respiratory symptoms and restricted airflow. It is a sickness that may be treated and avoided.
The burden of COPD is expected to rise even more in the near future due to the growth in population and increase in COPD risk factors such as tobacco usage, dust, chemicals, burning biomass fuel, and surging air pollution.
COPD care typically involves the usage of different devices to improve lung function, reduce side effects produced by COPD medication, and improve the patient's overall personal satisfaction. Inhalers are an important tool in COPD therapy, since they deliver medications directly to the inhalation paths.
Metered-portion inhalers (MDIs), dry powder inhalers (DPIs), and soft mist inhalers (SMIs) are some of the inhalers that have undergone continuous advancements in medication transportation proficiency, usability, and adaptability.
Some inhalers now feature concealed sensors that monitor consumption and provide feedback to consumers and medical care providers. Nebulizer, which transforms fluid medications into a fine fog, makes it easier for patients to breathe in the medicines.
Recent improvements in nebulizers for asthma management in children have focused on shortening treatment duration. These factors are expected to influence rapid development in the respiratory devices market.
Introduction of technologically advanced respiratory devices, such as sensors and pulse dose meters, that offer quality patient prognosis is expected to promote respiratory devices market development. These devices allow one to control the flow of oxygen.
Adoption of sophisticated respiratory breathing devices is becoming increasingly popular across the globe. Benefits provided by these devices include a quicker reaction rate, more efficient dosing, regulated flow, and increased dependability and durability.
Medical professionals and clinicians favor respiratory therapy devices for the treatment of a wide range of respiratory illnesses. In the case of emergency and chronic patient care, these devices enable instant medical intervention.
Rise in knowledge about the usage of respiratory devices, their advantages, and recent breakthroughs in the sector are projected to drive the respiratory devices industry in the near future. The usage of Portable Oxygen Concentrators for travel (POC) in a variety of applications, including emergency medicine, is emerging as a new opportunity for the global respiratory devices industry growth.
According to the latest respiratory devices market research, North America accounted for the largest share of the global landscape in 2022. The region's prominence can be ascribed to the existence of well-developed healthcare infrastructure, rise in population awareness, and continual technological improvements.
Increase in patient pool that is prone to respiratory disorders is also likely to boost North America’s respiratory devices market share during the projection period. Growth in prevalence of COPD is augmenting the demand for respiratory equipment, thus contributing to a positive market forecast during the forecast period.
As per respiratory devices market analysis, firms engaged in the manufacture of respiratory devices are launching products based on clinical urgency for higher mobility support for the senior population and rising need for portable technology. A diverse product selection is expected to help players establish widespread client base.
Some of the key players operating in the respiratory devices market are ResMed, Koninklijke Philips N.V., Vyaire Medical, Inc. (Becton, Dickinson and Company), Smiths Medical (part of Smiths Group plc), Fisher & Paykel Healthcare Limited, Drägerwerk AG & Co. KGaA, GE Healthcare (part of General Electric Company), Getinge AB, Medtronic plc, and Chart Industries.
Each of these players has been profiled in the respiratory devices market report based on parameters such as company overview, business strategies, financial overview, product portfolio, and business segments.
| Attribute | Detail |
|---|---|
| Market Value in 2022 (Base Year) | US$ 22.2 Bn |
| Market Forecast Value in 2031 | US$ 37.7 Bn |
| Growth Rate (CAGR) | 6.1% |
| Forecast Period | 2023-2031 |
| Historical Data Available for | 2017-2021 |
| Quantitative Units | US$ Bn for Value |
| Market Analysis | Qualitative analysis includes drivers, restraints, opportunities, key trends, key market indicators, Porter’s Five Forces analysis, value chain analysis, and SWOT analysis. Furthermore, at the regional level, the qualitative analysis includes key trends, price trends, and key supplier analysis. |
| Competition Landscape |
|
| Format | Electronic (PDF) + Excel |
| Market Segmentation |
|
| Regions Covered |
|
| Countries Covered |
|
| Companies Profiled |
|
| Customization Scope | Available upon Request |
| Pricing | Available upon Request |
It was valued at US$ 22.2 Bn in 2022
It is likely to grow at a CAGR of 6.1% from 2023 to 2031
High efficacy of respiratory devices in the treatment of COPD and rapid rate of technological advancements
North America was the leading region in 2022
ResMed, Koninklijke Philips N.V, and Vyaire Medical, Inc. (Becton, Dickinson and Company), Smiths Medical (part of Smiths Group plc), Fisher & Paykel Healthcare Limited, Drägerwerk AG & Co. KGaA, GE Healthcare (part of General Electric Company), Getinge AB, Medtronic plc, and Chart Industries
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Respiratory Devices Market
4. Market Overview
4.1. Introduction
4.1.1. Product Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Respiratory Devices Market Analysis and Forecast, 2017-2031
5. Key Insights
5.1. Pipeline Analysis
5.2. Key Product/Brand Analysis
5.3. Key Mergers & Acquisitions
5.4. COVID-19 Pandemic Impact on Industry
6. Global Respiratory Devices Market Analysis and Forecast, by Product Type
6.1. Introduction and Definitions
6.2. Key Findings/Developments
6.3. Market Value Forecast, by Product Type, 2017–2031
6.3.1. Therapeutic Devices
6.3.2. Diagnostic & Monitoring Devices
6.4. Market Attractiveness, by Product Type
7. Global Respiratory Devices Market Analysis and Forecast, by Therapeutic Devices
7.1. Introduction and Definitions
7.2. Key Findings/Developments
7.3. Market Value Forecast, by Therapeutic Devices, 2017–2031
7.3.1. Drug Delivery Devices
7.3.1.1. Nebulizers
7.3.1.2. Inhalers
7.3.2. Mechanical Ventilators
7.3.2.1. Invasive
7.3.2.2. Non-invasive
7.3.3. Continuous Positive Airway Pressure
7.3.3.1. Devices
7.3.3.2. Disposables
7.3.4. Resuscitators
7.3.4.1. Reusable
7.3.4.2. Disposables
7.3.5. Humidifiers
7.3.6. Airway Clearance Devices
7.3.7. Oxygen Concentrators
7.3.8. Consumables & Disposables
7.3.9. Others
7.3.10. 7.4 Market Attractiveness, by Therapeutic Devices
8. Global Respiratory Devices Market Analysis and Forecast, by Diagnostic & Monitoring Devices
8.1. Introduction and Definitions
8.2. Key Findings/Developments
8.3. Market Value Forecast, by Diagnostic & Monitoring Devices, 2017–2031
8.3.1. Pulse Oximeters
8.3.2. Capnographs
8.3.3. Spirometers
8.3.4. Polysomnographs
8.3.5. Peak Flow Meters
8.3.6. Gas Analyzers
8.3.7. Others
8.4. Market Attractiveness, by Diagnostic & Monitoring Devices
9. Global Respiratory Devices Market Analysis and Forecast, by Application
9.1. Introduction and Definitions
9.2. Key Findings/Developments
9.3. Market Value Forecast, by Application, 2017–2031
9.3.1. Chronic Obstructive Pulmonary Disease
9.3.2. Asthma
9.3.3. Obstructive Sleep Apnea
9.3.4. Respiratory Distress Syndrome
9.3.5. Cystic Fibrosis
9.3.6. Pneumonia
9.4. Market Attractiveness, by Application
10. Global Respiratory Devices Market Analysis and Forecast, by Region
10.1. Key Findings
10.2. Market Value Forecast, by Region, 2017–2031
10.2.1. North America
10.2.2. Europe
10.2.3. Asia Pacific
10.2.4. Latin America
10.2.5. Middle East & Africa
10.3. Market Attractiveness, by Region
11. North America Respiratory Devices Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast, by Product Type, 2017–2031
11.2.1. Therapeutic Devices
11.2.2. Diagnostic & Monitoring Devices
11.3. Market Attractiveness, by Product Type
11.4. Market Value Forecast, by Therapeutic Devices, 2017–2031
11.4.1. Drug Delivery Devices
11.4.1.1. Nebulizers
11.4.1.2. Inhalers
11.4.2. Mechanical Ventilators
11.4.2.1. Invasive
11.4.2.2. Non-invasive
11.4.3. Continuous Positive Airway Pressure
11.4.3.1. Devices
11.4.3.2. Disposables
11.4.4. Resuscitators
11.4.4.1. Reusable
11.4.4.2. Disposables
11.4.5. Humidifiers
11.4.6. Airway Clearance Devices
11.4.7. Oxygen Concentrators
11.4.8. Consumables & Disposables
11.4.9. Others
11.5. Market Attractiveness, by Therapeutic Devices
11.6. Market Value Forecast, by Diagnostic & Monitoring Devices, 2017–2031
11.6.1. Pulse Oximeters
11.6.2. Capnographs
11.6.3. Spirometers
11.6.4. Polysomnographs
11.6.5. Peak Flow Meters
11.6.6. Gas Analyzers
11.6.7. Others
11.7. Market Attractiveness, by Diagnostic & Monitoring Devices
11.8. Market Value Forecast, by Application, 2017–2031
11.8.1. Chronic Obstructive Pulmonary Disease
11.8.2. Asthma
11.8.3. Obstructive Sleep Apnea
11.8.4. Respiratory Distress Syndrome
11.8.5. Cystic Fibrosis
11.8.6. Pneumonia
11.9. Market Attractiveness, by Application
11.10. Market Value Forecast, by Country/Sub-region, 2017–2031
11.10.1. U.S.
11.10.2. Canada
11.11. Market Attractiveness Analysis
11.11.1. By Product Type
11.11.2. By Therapeutic Devices
11.11.3. By Diagnostic & Monitoring Devices
11.11.4. By Application
11.11.5. By Country
12. Europe Respiratory Devices Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Product Type, 2017–2031
12.2.1. Therapeutic Devices
12.2.2. Diagnostic & Monitoring Devices
12.3. Market Attractiveness, by Product Type
12.4. Market Value Forecast, by Therapeutic Devices, 2017–2031
12.4.1. Drug Delivery Devices
12.4.1.1. Nebulizers
12.4.1.2. Inhalers
12.4.2. Mechanical Ventilators
12.4.2.1. Invasive
12.4.2.2. Non-invasive
12.4.3. Continuous Positive Airway Pressure
12.4.3.1. Devices
12.4.3.2. Disposables
12.4.4. Resuscitators
12.4.4.1. Reusable
12.4.4.2. Disposables
12.4.5. Humidifiers
12.4.6. Airway Clearance Devices
12.4.7. Oxygen Concentrators
12.4.8. Consumables & Disposables
12.4.9. Others
12.5. Market Attractiveness, by Therapeutic Devices
12.6. Market Value Forecast, by Diagnostic & Monitoring Devices, 2017–2031
12.6.1. Pulse Oximeters
12.6.2. Capnographs
12.6.3. Spirometers
12.6.4. Polysomnographs
12.6.5. Peak Flow Meters
12.6.6. Gas Analyzers
12.6.7. Others
12.7. Market Attractiveness, by Diagnostic & Monitoring Devices
12.8. Market Value Forecast, by Application, 2017–2031
12.8.1. Chronic Obstructive Pulmonary Disease
12.8.2. Asthma
12.8.3. Obstructive Sleep Apnea
12.8.4. Respiratory Distress Syndrome
12.8.5. Cystic Fibrosis
12.8.6. Pneumonia
12.9. Market Attractiveness, by Application
12.10. Market Value Forecast, by Country/Sub-region, 2017–2031
12.10.1. Germany
12.10.2. U.K.
12.10.3. France
12.10.4. Italy
12.10.5. Spain
12.10.6. Rest of Europe
12.11. Market Attractiveness Analysis
12.11.1. By Product Type
12.11.2. By Therapeutic Devices
12.11.3. By Diagnostic & Monitoring Devices
12.11.4. By Application
12.11.5. By Country/Sub-region
13. Asia Pacific Respiratory Devices Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Product Type, 2017–2031
13.2.1. Therapeutic Devices
13.2.2. Diagnostic & Monitoring Devices
13.3. Market Attractiveness, by Product Type
13.4. Market Value Forecast, by Therapeutic Devices, 2017–2031
13.4.1. Drug Delivery Devices
13.4.1.1. Nebulizers
13.4.1.2. Inhalers
13.4.2. Mechanical Ventilators
13.4.2.1. Invasive
13.4.2.2. Non-invasive
13.4.3. Continuous Positive Airway Pressure
13.4.3.1. Devices
13.4.3.2. Disposables
13.4.4. Resuscitators
13.4.4.1. Reusable
13.4.4.2. Disposables
13.4.5. Humidifiers
13.4.6. Airway Clearance Devices
13.4.7. Oxygen Concentrators
13.4.8. Consumables & Disposables
13.4.9. Others
13.5. Market Attractiveness, by Therapeutic Devices
13.6. Market Value Forecast, by Diagnostic & Monitoring Devices, 2017–2031
13.6.1. Pulse Oximeters
13.6.2. Capnographs
13.6.3. Spirometers
13.6.4. Polysomnographs
13.6.5. Peak Flow Meters
13.6.6. Gas Analyzers
13.6.7. Others
13.7. Market Attractiveness, by Diagnostic & Monitoring Devices
13.8. Market Value Forecast, by Application, 2017–2031
13.8.1. Chronic Obstructive Pulmonary Disease
13.8.2. Asthma
13.8.3. Obstructive Sleep Apnea
13.8.4. Respiratory Distress Syndrome
13.8.5. Cystic Fibrosis
13.8.6. Pneumonia
13.9. Market Attractiveness, by Application
13.10. Market Value Forecast, by Country/Sub-region, 2017–2031
13.10.1. China
13.10.2. Japan
13.10.3. India
13.10.4. Australia & New Zealand
13.10.5. Rest of Asia Pacific
13.11. Market Attractiveness Analysis
13.11.1. By Product Type
13.11.2. By Therapeutic Devices
13.11.3. By Diagnostic & Monitoring Devices
13.11.4. By Application
13.11.5. By Country/Sub-region
14. Latin America Respiratory Devices Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast, by Product Type, 2017–2031
14.2.1. Therapeutic Devices
14.2.2. Diagnostic & Monitoring Devices
14.3. Market Attractiveness, by Product Type
14.4. Market Value Forecast, by Therapeutic Devices, 2017–2031
14.4.1. Drug Delivery Devices
14.4.1.1. Nebulizers
14.4.1.2. Inhalers
14.4.2. Mechanical Ventilators
14.4.2.1. Invasive
14.4.2.2. Non-invasive
14.4.3. Continuous Positive Airway Pressure
14.4.3.1. Devices
14.4.3.2. Disposables
14.4.4. Resuscitators
14.4.4.1. Reusable
14.4.4.2. Disposables
14.4.5. Humidifiers
14.4.6. Airway Clearance Devices
14.4.7. Oxygen Concentrators
14.4.8. Consumables & Disposables
14.4.9. Others
14.5. Market Attractiveness, by Therapeutic Devices
14.6. Market Value Forecast, by Diagnostic & Monitoring Devices, 2017–2031
14.6.1. Pulse Oximeters
14.6.2. Capnographs
14.6.3. Spirometers
14.6.4. Polysomnographs
14.6.5. Peak Flow Meters
14.6.6. Gas Analyzers
14.6.7. Others
14.7. Market Attractiveness, by Diagnostic & Monitoring Devices
14.8. Market Value Forecast, by Application, 2017–2031
14.8.1. Chronic Obstructive Pulmonary Disease
14.8.2. Asthma
14.8.3. Obstructive Sleep Apnea
14.8.4. Respiratory Distress Syndrome
14.8.5. Cystic Fibrosis
14.8.6. Pneumonia
14.9. Market Attractiveness, by Application
14.10. Market Value Forecast, by Country/Sub-region, 2017–2031
14.10.1. Brazil
14.10.2. Mexico
14.10.3. Rest of Latin America
14.11. Market Attractiveness Analysis
14.11.1. By Product Type
14.11.2. By Therapeutic Devices
14.11.3. By Diagnostic & Monitoring Devices
14.11.4. By Application
14.11.5. By Country/Sub-region
15. Middle East & Africa Respiratory Devices Market Analysis and Forecast
15.1. Introduction
15.1.1. Key Findings
15.2. Market Value Forecast, by Product Type, 2017–2031
15.2.1. Therapeutic Devices
15.2.2. Diagnostic & Monitoring Devices
15.3. Market Attractiveness, by Product Type
15.4. Market Value Forecast, by Therapeutic Devices, 2017–2031
15.4.1. Drug Delivery Devices
15.4.1.1. Nebulizers
15.4.1.2. Inhalers
15.4.2. Mechanical Ventilators
15.4.2.1. Invasive
15.4.2.2. Non-invasive
15.4.3. Continuous Positive Airway Pressure
15.4.3.1. Devices
15.4.3.2. Disposables
15.4.4. Resuscitators
15.4.4.1. Reusable
15.4.4.2. Disposables
15.4.5. Humidifiers
15.4.6. Airway Clearance Devices
15.4.7. Oxygen Concentrators
15.4.8. Consumables & Disposables
15.4.9. Others
15.5. Market Attractiveness, by Therapeutic Devices
15.6. Market Value Forecast, by Diagnostic & Monitoring Devices, 2017–2031
15.6.1. Pulse Oximeters
15.6.2. Capnographs
15.6.3. Spirometers
15.6.4. Polysomnographs
15.6.5. Peak Flow Meters
15.6.6. Gas Analyzers
15.6.7. Others
15.7. Market Attractiveness, by Diagnostic & Monitoring Devices
15.8. Market Value Forecast, by Application, 2017–2031
15.8.1. Chronic Obstructive Pulmonary Disease
15.8.2. Asthma
15.8.3. Obstructive Sleep Apnea
15.8.4. Respiratory Distress Syndrome
15.8.5. Cystic Fibrosis
15.8.6. Pneumonia
15.9. Market Attractiveness, by Application
15.10. Market Value Forecast, by Country/Sub-region, 2017–2031
15.10.1. GCC Countries
15.10.2. South Africa
15.10.3. Rest of Middle East & Africa
15.11. Market Attractiveness Analysis
15.11.1. By Product Type
15.11.2. By Therapeutic Devices
15.11.3. By Diagnostic & Monitoring Devices
15.11.4. By Application
15.11.5. By Country/Sub-region
16. Competition Landscape
16.1. Market Player - Competition Matrix (By Tier and Size of Companies)
16.2. Market Share Analysis, by Company (2022)
16.3. Company Profiles
16.3.1. ResMed
16.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.1.2. Product Portfolio
16.3.1.3. Financial Overview
16.3.1.4. SWOT Analysis
16.3.1.5. Strategic Overview
16.3.2. Koninklijke Philips N.V.
16.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.2.2. Product Portfolio
16.3.2.3. Financial Overview
16.3.2.4. SWOT Analysis
16.3.2.5. Strategic Overview
16.3.3. Vyaire Medical
16.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.3.2. Product Portfolio
16.3.3.3. Financial Overview
16.3.3.4. SWOT Analysis
16.3.3.5. Strategic Overview
16.3.4. Smiths Medical
16.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.4.2. Product Portfolio
16.3.4.3. Financial Overview
16.3.4.4. SWOT Analysis
16.3.4.5. Strategic Overview
16.3.5. Fisher & Paykel Healthcare Limited
16.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.5.2. Product Portfolio
16.3.5.3. Financial Overview
16.3.5.4. SWOT Analysis
16.3.5.5. Strategic Overview
16.3.6. Drägerwerk AG & Co.
16.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.6.2. Product Portfolio
16.3.6.3. Financial Overview
16.3.6.4. SWOT Analysis
16.3.6.5. Strategic Overview
16.3.7. GE Healthcare
16.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.7.2. Product Portfolio
16.3.7.3. Financial Overview
16.3.7.4. SWOT Analysis
16.3.7.5. Strategic Overview
16.3.8. Getinge AB
16.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.8.2. Product Portfolio
16.3.8.3. Financial Overview
16.3.8.4. SWOT Analysis
16.3.8.5. Strategic Overview
16.3.9. Medtronic plc
16.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.9.2. Product Portfolio
16.3.9.3. Financial Overview
16.3.9.4. SWOT Analysis
16.3.9.5. Strategic Overview
16.3.10. Chart Industries
16.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.10.2. Product Portfolio
16.3.10.3. Financial Overview
16.3.10.4. SWOT Analysis
16.3.10.5. Strategic Overview
List of Tables
Table 01: Global Respiratory Devices Market Size (US$ Mn) Forecast, by Product Type, 2017–2031
Table 02: Global Respiratory Devices Market Size (US$ Mn) Forecast, by Therapeutic Devices, 2017–2031
Table 03: Global Respiratory Devices Market Size (US$ Mn) Forecast, by Application, 2017–2031
Table 04: Global Respiratory Devices Market Size (US$ Mn) Forecast, by Diagnostic & Monitoring Devices, 2017–2031
Table 05: Global Respiratory Devices Market Size (US$ Mn) Forecast, by Region, 2017–2031
Table 06: North America Respiratory Devices Market Size (US$ Mn) Forecast, by Country, 2017–2031
Table 07: North America Respiratory Devices Market Size (US$ Mn) Forecast, by Product Type, 2017–2031
Table 08: North America Respiratory Devices Market Size (US$ Mn) Forecast, by Therapeutic Devices, 2017–2031
Table 9: North America Respiratory Devices Market Size (US$ Mn) Forecast, by Diagnostic & Monitoring Devices, 2017–2031
Table 10: North America Respiratory Devices Market Size (US$ Mn) Forecast, by Application, 2017–2031
Table 11: Europe Respiratory Devices Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 12: Europe Respiratory Devices Market Size (US$ Mn) Forecast, by Product Type, 2017–2031
Table 13: Europe Respiratory Devices Market Size (US$ Mn) Forecast, by Therapeutic Devices, 2017–2031
Table 14: Europe Respiratory Devices Market Size (US$ Mn) Forecast, by Diagnostic & Monitoring Devices, 2017–2031
Table 15: Europe Respiratory Devices Market Size (US$ Mn) Forecast, by Application, 2017–2031
Table 16: Asia Pacific Respiratory Devices Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 17: Asia Pacific Respiratory Devices Market Size (US$ Mn) Forecast, by Product Type, 2017–2031
Table 18: Asia Pacific Respiratory Devices Market Size (US$ Mn) Forecast, by Therapeutic Devices, 2017–2031
Table 19: Asia Pacific Respiratory Devices Market Size (US$ Mn) Forecast, by Diagnostic & Monitoring Devices, 2017–2031
Table 20: Asia Pacific Respiratory Devices Market Size (US$ Mn) Forecast, by Application, 2017–2031
Table 21: Latin America Respiratory Devices Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 22: Latin America Respiratory Devices Market Size (US$ Mn) Forecast, by Product Type, 2017–2031
Table 23: Latin America Respiratory Devices Market Size (US$ Mn) Forecast, by Therapeutic Devices, 2017–2031
Table 24: Latin America Respiratory Devices Market Size (US$ Mn) Forecast, by Diagnostic & Monitoring Devices, 2017–2031
Table 25: Latin America Respiratory Devices Market Size (US$ Mn) Forecast, by Application, 2017–2031
Table 26: Middle East & Africa Respiratory Devices Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 27: Middle East & Africa Respiratory Devices Market Size (US$ Mn) Forecast, by Product Type, 2017–2031
Table 28: Middle East & Africa Respiratory Devices Market Size (US$ Mn) Forecast, by Therapeutic Devices, 2017–2031
Table 29: Middle East & Africa Respiratory Devices Market Size (US$ Mn) Forecast, by Diagnostic & Monitoring Devices, 2017–2031
Table 30: Middle East & Africa Respiratory Devices Market Size (US$ Mn) Forecast, by Application, 2017–2031
List of Figures
Figure 01: Global Respiratory Devices Market Size (US$ Mn), by Region, 2022 and 2031
Figure 02: Global Respiratory Devices Market Revenue (US$ Mn), by Product Type, 2022
Figure 03: Global Respiratory Devices Market Value Share, by Product Type, 2022
Figure 04: Global Respiratory Devices Market Revenue (US$ Mn), by Therapeutic Devices, 2022
Figure 05: Global Respiratory Devices Market Value Share, by Therapeutic Devices, 2022
Figure 06: Global Respiratory Devices Market Revenue (US$ Mn), by Diagnostic & Monitoring Devices, 2022
Figure 07: Global Respiratory Devices Market Value Share, by Diagnostic & Monitoring Devices, 2022
Figure 08: Global Respiratory Devices Market Revenue (US$ Mn), by Application, 2022
Figure 09: Global Respiratory Devices Market Value Share, by Application, 2022
Figure 10: Global Respiratory Devices Market Value Share, by Region, 2022
Figure 11: Global Respiratory Devices Market Value (US$ Mn) Forecast, 2017–2031
Figure 12: Global Respiratory Devices Market Value Share Analysis, by Product Type, 2022 and 2031
Figure 13: Global Respiratory Devices Market Attractiveness Analysis, by Product Type, 2023-2031
Figure 14: Global Respiratory Devices Market Value Share Analysis, by Therapeutic Devices, 2022 and 2031
Figure 15: Global Respiratory Devices Market Attractiveness Analysis, by Therapeutic Devices, 2023-2031
Figure 16: Global Respiratory Devices Market Value Share Analysis, by Diagnostic & Monitoring Devices, 2022 and 2031
Figure 17: Global Respiratory Devices Market Attractiveness Analysis, by Diagnostic & Monitoring Devices, 2023-2031
Figure 18: Global Respiratory Devices Market Revenue (US$ Mn), by Application, 2022
Figure 19: Global Respiratory Devices Market Value Share, by Application, 2022
Figure 20: Global Respiratory Devices Market Value Share Analysis, by Region, 2022 and 2031
Figure 21: Global Respiratory Devices Market Attractiveness Analysis, by Region, 2023-2031
Figure 22: North America Respiratory Devices Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031
Figure 23: North America Respiratory Devices Market Attractiveness Analysis, by Country, 2023–2031
Figure 24: North America Respiratory Devices Market Value Share Analysis, by Country, 2022 and 2031
Figure 25: North America Respiratory Devices Market Value Share Analysis, by Product Type, 2022 and 2031
Figure 26: North America Respiratory Devices Market Value Share Analysis, by Therapeutic Devices, 2022 and 2031
Figure 27: North America Respiratory Devices Market Value Share Analysis, by Diagnostic & Monitoring Devices, 2022 and 2031
Figure 28: North America Respiratory Devices Market Value Share Analysis, by Application, 2022 and 2031
Figure 29: North America Respiratory Devices Market Attractiveness Analysis, by Product Type, 2023–2031
Figure 30: North America Respiratory Devices Market Attractiveness Analysis, by Therapeutic Devices, 2023–2031
Figure 31: North America Respiratory Devices Market Attractiveness Analysis, by Diagnostic & Monitoring Devices, 2023–2031
Figure 32: North America Respiratory Devices Market Attractiveness Analysis, by Application, 2023–2031
Figure 33: Europe Respiratory Devices Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031
Figure 34: Europe Respiratory Devices Market Attractiveness Analysis, by Country/Sub-region, 2023–2031
Figure 35: Europe Respiratory Devices Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
Figure 36: Europe Respiratory Devices Market Value Share Analysis, by Product Type, 2022 and 2031
Figure 37: Europe Respiratory Devices Market Value Share Analysis, by Therapeutic Devices, 2022 and 2031
Figure 38: Europe Respiratory Devices Market Value Share Analysis, by Diagnostic & Monitoring Devices, 2022 and 2031
Figure 39: Europe Respiratory Devices Market Value Share Analysis, by Application, 2022 and 2031
Figure 40: Europe Respiratory Devices Market Attractiveness Analysis, by Product Type, 2023–2031
Figure 41: Europe Respiratory Devices Market Attractiveness Analysis, by Therapeutic Devices, 2023–2031
Figure 42: Europe Respiratory Devices Market Attractiveness Analysis, by Diagnostic & Monitoring Devices, 2023–2031
Figure 43: Europe Respiratory Devices Market Attractiveness Analysis, by Application, 2023–2031
Figure 44: Asia Pacific Respiratory Devices Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031
Figure 45: Asia Pacific Respiratory Devices Market Attractiveness Analysis, by Country/Sub-region, 2023–2031
Figure 46: Asia Pacific Respiratory Devices Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
Figure 47: Asia Pacific Respiratory Devices Market Value Share Analysis, by Product Type, 2022 and 2031
Figure 48: Asia Pacific Respiratory Devices Market Value Share Analysis, by Therapeutic Devices, 2022 and 2031
Figure 49: Asia Pacific Respiratory Devices Market Value Share Analysis, by Diagnostic & Monitoring Devices, 2022 and 2031
Figure 50: Asia Pacific Respiratory Devices Market Value Share Analysis, by Application, 2022 and 2031
Figure 51: Asia Pacific Respiratory Devices Market Attractiveness Analysis, by Product Type, 2023–2031
Figure 52: Asia Pacific Respiratory Devices Market Attractiveness Analysis, by Therapeutic Devices, 2023–2031
Figure 53: Asia Pacific Respiratory Devices Market Attractiveness Analysis, by Diagnostic & Monitoring Devices, 2023–2031
Figure 54: Asia Pacific Respiratory Devices Market Attractiveness Analysis, by Application, 2022–2031
Figure 55: Latin America Respiratory Devices Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031
Figure 56: Latin America Respiratory Devices Market Attractiveness Analysis, by Country/Sub-region, 2023–2031
Figure 57: Latin America Respiratory Devices Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
Figure 58: Latin America Respiratory Devices Market Value Share Analysis, by Product Type, 2022 and 2031
Figure 59: Latin America Respiratory Devices Market Value Share Analysis, by Therapeutic Devices, 2022 and 2031
Figure 60: Latin America Respiratory Devices Market Value Share Analysis, by Diagnostic & Monitoring Devices, 2022 and 2031
Figure 61: Latin America Respiratory Devices Market Value Share Analysis, by Application, 2022 and 2031
Figure 62: Latin America Respiratory Devices Market Attractiveness Analysis, by Product Type, 2023–2031
Figure 63: Latin America Respiratory Devices Market Attractiveness Analysis, by Therapeutic Devices, 2023–2031
Figure 64: Latin America Respiratory Devices Market Attractiveness Analysis, by Diagnostic & Monitoring Devices, 2023–2031
Figure 65: Latin America Respiratory Devices Market Attractiveness Analysis, by Application, 2023–2031
Figure 66: Middle East & Africa Respiratory Devices Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031
Figure 67: Middle East & Africa Respiratory Devices Market Attractiveness Analysis, by Country/Sub-region, 2023–2031
Figure 68: Middle East & Africa Respiratory Devices Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
Figure 69: Middle East & Africa Respiratory Devices Market Value Share Analysis, by Product Type, 2022 and 2031
Figure 70: Middle East & Africa Respiratory Devices Market Value Share Analysis, by Therapeutic Devices, 2022 and 2031
Figure 71: Middle East & Africa Respiratory Devices Market Value Share Analysis, by Diagnostic & Monitoring Devices, 2022 and 2031
Figure 72: Middle East & Africa Respiratory Devices Market Value Share Analysis, by Application, 2022 and 2031
Figure 73: Middle East & Africa Respiratory Devices Market Attractiveness Analysis, by Product Type, 2023–2031
Figure 74: Middle East & Africa Respiratory Devices Market Attractiveness Analysis, by Therapeutic Devices, 2023–2031
Figure 75: Middle East & Africa Respiratory Devices Market Attractiveness Analysis, by Diagnostic & Monitoring Devices, 2023–2031
Figure 76: Middle East & Africa Respiratory Devices Market Attractiveness Analysis, by Application, 2023–2031
Copyright © Transparency Market Research, Inc. All Rights reserved
Trust Online
Respiratory Devices Market
